Serina Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Serina Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $8.00K, a 700.00% increase year-over-year.
- Serina Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $8.00K, a 90.70% decline year-over-year.
- Serina Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.00K.
- Serina Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $1.00K, a 75.00% decline year-over-year.
- Serina Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $15.00K, a 25.00% increase from fiscal 2024.
- Serina Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $12.00K, a 20.00% decline from fiscal 2023.
- Serina Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $15.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-03-31 | $8.00K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $15.00K 10-K · filed 2026-03-25 | |
| 2025-09-30 | $8.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $1.00K 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $12.00K 10-K · filed 2026-03-25 | |
| 2024-09-30 | $86.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | |
| 2024-03-31 | $4.00K 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $15.00K 10-K · filed 2025-03-24 | |
| 2023-09-30 | $13.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $1.00K 10-Q · filed 2024-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |